Newswise — FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, announces the availability of printed versions of the NCCN Guidelines for Patients® for order on Amazon.com for the following cancer types: Breast (Stages 0 – IV), Colon, and Pancreatic Cancers; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; and Soft Tissue Sarcoma. Newly redesigned, these patient resources offer user-friendly navigation in print and on digital devices. Additional cancer types are expected to be available on Amazon.com in the coming months.

NCCN Guidelines for Patients, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are designed to provide people with cancer and their caregivers with state-of-the-art treatment information in easy-to-understand language.

“The ability to order printed NCCN Guidelines for Patients further enhances the mission of the NCCN Foundation to empower people through knowledge and advance the mission of NCCN to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives,” said Marcie Reeder, MPH, Executive Director, NCCN Foundation. “Now patients and those involved in their care can readily access both digital and hard copy versions of the NCCN Guidelines for Patients.”

The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature sequential algorithms that address appropriate management options from initial work-up through treatment and surveillance. The NCCN Guidelines for Patients are translations of the NCCN Guidelines. These patient gu¬idelines are meant to help people with cancer talk with their physicians about the best treatment options for their disease. NCCN Guidelines for Patients do not replace the expertise and clinical judgment of the physician.

Digital versions of the library of NCCN Guidelines for Patients are available for download for free on NCCN.org/patients. NCCN currently offers digital patient resources for breast, colon, esophageal, non-small cell lung, ovarian, pancreatic, and prostate cancers; chronic myelogenous leukemia; malignant pleural mesothelioma; melanoma; multiple myeloma; and soft tissue sarcoma; as well as caring for adolescents and young adults (AYA) and lung cancer screening.

For more information about the NCCN Guidelines for Patients or to order printed copies, visit NCCN.org/patients.

###

About the National Comprehensive Cancer NetworkThe National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.

The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center at The Nebraska Medical Center, Omaha, NE; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.

Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients.